Edwards Lifesciences Corp Cash Flow Quality Index
Edwards Lifesciences Corp cash flow quality index. Edwards Lifesciences Corp (EW) has a Cash Flow Quality Index of 2.70x as of June 2026. Operating cash flow of $651.90 Million exceeds net income of $241.40 Million, indicating high earnings quality where cash backs reported profits. See Edwards Lifesciences Corp financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Edwards Lifesciences Corp (1999–2025)
Cash flow quality index of Edwards Lifesciences Corp from 1999 to 2025. Historical Cash Flow Quality Index for Edwards Lifesciences Corp across 25 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore EW cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Edwards Lifesciences Corp Cash Flow Quality Index by Year (1999–2025)
Edwards Lifesciences Corp cash flow quality index by year from 1999 to 2025. Year-by-year earnings quality comparison for Edwards Lifesciences Corp. For the full cash flow conversion analysis, see EW cash generation efficiency.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.49x | $1.60 Billion | $1.07 Billion | ▲ +1046.9% |
| 2024 | 0.13x | $542.30 Million | $4.17 Billion | ▼ -79.6% |
| 2023 | 0.64x | $895.80 Million | $1.40 Billion | ▼ -20.2% |
| 2022 | 0.80x | $1.22 Billion | $1.52 Billion | ▼ -30.5% |
| 2021 | 1.15x | $1.73 Billion | $1.50 Billion | ▼ -10.0% |
| 2020 | 1.28x | $1.05 Billion | $823.40 Million | ▲ +13.7% |
| 2019 | 1.13x | $1.18 Billion | $1.05 Billion | ▼ -12.2% |
| 2018 | 1.28x | $926.80 Million | $722.20 Million | ▼ -25.2% |
| 2017 | 1.71x | $1.00 Billion | $583.60 Million | ▲ +38.6% |
| 2016 | 1.24x | $704.40 Million | $569.50 Million | ▲ +11.4% |
| 2015 | 1.11x | $549.70 Million | $494.90 Million | ▼ -11.9% |
| 2014 | 1.26x | $1.02 Billion | $811.10 Million | ▲ +4.4% |
| 2013 | 1.21x | $472.70 Million | $391.70 Million | ▼ -5.3% |
| 2012 | 1.27x | $373.80 Million | $293.20 Million | ▼ -4.0% |
| 2011 | 1.33x | $314.50 Million | $236.70 Million | ▲ +15.2% |
| 2010 | 1.15x | $251.40 Million | $218.00 Million | ▲ +59.8% |
| 2009 | 0.72x | $165.30 Million | $229.10 Million | ▼ -39.3% |
| 2008 | 1.19x | $153.20 Million | $128.90 Million | ▼ -36.1% |
| 2007 | 1.86x | $210.20 Million | $113.00 Million | ▲ +5.2% |
| 2006 | 1.77x | $230.80 Million | $130.50 Million | ▲ +2.5% |
| 2005 | 1.73x | $136.80 Million | $79.30 Million | ▼ -98.4% |
| 2004 | 106.24x | $180.60 Million | $1.70 Million | ▲ +6762.3% |
| 2003 | 1.55x | $122.30 Million | $79.00 Million | ▼ -28.5% |
| 2002 | 2.17x | $120.60 Million | $55.70 Million | ▲ +0.9% |
| 1999 | 2.15x | $176.00 Million | $82.00 Million | — |